These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 7044593)

  • 41. Treatment strategies in relation to drug action.
    Muggia FM; McVie G
    NCI Monogr; 1987; (4):129-33. PubMed ID: 2819724
    [No Abstract]   [Full Text] [Related]  

  • 42. A case of small cell lung cancer successfully treated with VM26.
    Suga J; Saijo N; Shinkai T; Eguchi K; Sasaki Y; Sakurai M; Sano T; Tamura T; Morinaga S
    Jpn J Clin Oncol; 1986 Jun; 16(2):123-8. PubMed ID: 3016377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent advances in semisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: an update (2008-2010).
    Lv M; Xu H
    Mini Rev Med Chem; 2011 Sep; 11(10):901-9. PubMed ID: 21781026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. VM26 therapy in children with drug-refractory lymphocytic leukemia.
    Rivera G; Dahl GV; Murphy SB; Bowman WP; Aur RJ; Avery TL; Simone JV
    Cancer Chemother Pharmacol; 1982; 7(2-3):169-72. PubMed ID: 7083458
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung.
    Roed H; Vindelov LL; Christensen IJ; Spang-Thomsen M; Hansen HH
    Cancer Chemother Pharmacol; 1987; 19(1):16-20. PubMed ID: 3815721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Teniposide: a review of 12 years of experience.
    O'Dwyer PJ; Alonso MT; Leyland-Jones B; Marsoni S
    Cancer Treat Rep; 1984 Dec; 68(12):1455-66. PubMed ID: 6391663
    [No Abstract]   [Full Text] [Related]  

  • 47. Synthesis and biological activities of the C-4 esters of 4'-demethylepipodophyllotoxin.
    Gupta RS; Chenchaiah PC
    Anticancer Drug Des; 1987 Aug; 2(1):13-23. PubMed ID: 3449082
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 4'-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) and 4'-demethylepipodophyllotoxin 9-(4.6-0-ethylidene-beta-D-glucopyranoside) (NSC-141540; VP-16-213) in childhood cancer: preliminary observations.
    Rivera G; Avery T; Pratt C
    Cancer Chemother Rep; 1975; 59(4):743-9. PubMed ID: 1100225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A radioimmunoassay for VP16-213 in plasma.
    Aherne GW; Marks V
    Cancer Chemother Pharmacol; 1982; 7(2-3):117-21. PubMed ID: 7083451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase II study of teniposide in small cell carcinoma of the lung.
    Pedersen AG; Bork E; Osterlind K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1984 Oct; 68(10):1289-91. PubMed ID: 6098366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antitumor properties of podophyllotoxin and related compounds.
    Gordaliza M; Castro MA; del Corral JM; Feliciano AS
    Curr Pharm Des; 2000 Dec; 6(18):1811-39. PubMed ID: 11102564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. VM26 in malignant hematological diseases. A phase II study.
    Tirelli U; Carbone A; Franchin G; Galligioni E; Veronesi A; Trovo MG; Volpe R; Tumolo S; Grigoletto E
    Cancer Chemother Pharmacol; 1982; 7(2-3):173-4. PubMed ID: 6952964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sequential cis-platinum and VM26 in neuroblastoma: laboratory and clinical (OPEC regimen) studies.
    Pritchard J; Whelan R; Hill BT
    Prog Clin Biol Res; 1985; 175():545-55. PubMed ID: 4039448
    [No Abstract]   [Full Text] [Related]  

  • 54. Discovery of podophyllotoxins.
    Imbert TF
    Biochimie; 1998 Mar; 80(3):207-22. PubMed ID: 9615861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimetastasis effect of two derivatives of epiposophyllotoxin in mice.
    Cattan A; Pourny C; Carpentier Y; Cattan E; Barouh M
    Eur J Cancer (1965); 1976 Oct; 12(10):797-805. PubMed ID: 976288
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison between VP 16 and VM 26 in Lewis lung carcinoma of the mouse.
    Colombo T; Broggini M; Vaghi M; Amato G; Erba E; D'Incalci M
    Eur J Cancer Clin Oncol; 1986 Feb; 22(2):173-9. PubMed ID: 3699080
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Review of etoposide.
    Phillips NC; Lauper RD
    Clin Pharm; 1983; 2(2):112-9. PubMed ID: 6309469
    [No Abstract]   [Full Text] [Related]  

  • 58. Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.
    Oishi N; Berenberg J; Blumenstein BA; Johnson K; Rivkin SE; Bukowski RM; O'Bryan RM; Stephens RL; Quagliana J; Saiers JH
    Cancer Treat Rep; 1987 Dec; 71(12):1307-8. PubMed ID: 3690547
    [No Abstract]   [Full Text] [Related]  

  • 59. [Association of VM26, mitomycine C, methotrexate in patients with metastatic carcinoma of the breast resistant to a combination of 4 drugs including adriamycin. Results of a type II study (autohr's transl)].
    Pouillart P; Palangie T; Jouve M; Garcia-Giralt E; Magdelenat H
    Nouv Presse Med; 1979 Aug 25-Sep 3; 8(33):2690. PubMed ID: 493073
    [No Abstract]   [Full Text] [Related]  

  • 60. Anaphylactic reactions to teniposide.
    Siddall SJ; Martin J; Nunn AJ
    Lancet; 1989 Feb; 1(8634):394. PubMed ID: 2563558
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.